| scholarly article | Q13442814 |
| P356 | DOI | 10.1160/TH03-04-0247 |
| P698 | PubMed publication ID | 14691580 |
| P2093 | author name string | Toshiji Iwasaka | |
| Yutaka Kimura | |||
| Shosaku Nomura | |||
| Hiroshi Kamihata | |||
| Noriko Matsumoto | |||
| P2860 | cites work | Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study | Q56765457 |
| P433 | issue | 1 | |
| P921 | main subject | acute coronary syndrome | Q266018 |
| P304 | page(s) | 146-154 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome | |
| P478 | volume | 91 |
| Q41556597 | A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction |
| Q37365537 | Altered Maturation Status and Possible Immune Exhaustion of CD8 T Lymphocytes in the Peripheral Blood of Patients Presenting With Acute Coronary Syndromes |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q92853263 | Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis |
| Q35908304 | Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation |
| Q91839670 | Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q45740077 | Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation |
| Q42986020 | Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles |
| Q93133348 | Effects of Cryopreservation on Microparticles Concentration, Procoagulant Function, Size Distribution, and Morphology |
| Q35391967 | Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia |
| Q38908954 | Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure |
| Q39107240 | Extracellular vesicles and blood diseases |
| Q27024964 | Hyperlipidemia, tissue factor, coagulation, and simvastatin |
| Q83667734 | Increased plasma level of asymmetric dimethylarginine in hypertensive rats facilitates platelet aggregation: role of plasma tissue factor |
| Q38902823 | Interleukin-10 microsatellite variants and the risk of acute coronary syndrome among Tunisians |
| Q26783691 | Microparticles as Biomarkers of Blood Coagulation in Cancer |
| Q35131040 | Microparticles in hemostasis and thrombosis. |
| Q40679113 | Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin |
| Q27023547 | On the origin of microparticles: From "platelet dust" to mediators of intercellular communication |
| Q35872535 | Oxidized Low-Density Lipoprotein-Dependent Platelet-Derived Microvesicles Trigger Procoagulant Effects and Amplify Oxidative Stress |
| Q36445823 | Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI |
| Q34488533 | Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population |
| Q38034092 | Role of tissue factor in atherothrombosis |
| Q37996577 | Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque |
| Q36564652 | The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia. |
| Q80088629 | [Markers of thrombotic disease: procoagulant microparticles] |
Search more.